Related Experiment Videos
Cyclin D1 expression in dysplastic nevi: an immunohistochemical study
C Ewanowich1, R K Brynes, L Medeiros
1Department of Laboratory Medicine & Pathology, University of Alberta, Edmonton, Alberta, Canada.
Archives of Pathology & Laboratory Medicine
|February 15, 2001
Summary
Cyclin D1 overexpression in dysplastic nevi shows a zonal pattern, correlating with atypia. This overexpression is not due to gene amplification or translocation, suggesting other cellular abnormalities in dysplastic nevus development.
Area of Science:
- Dermatopathology
- Molecular Biology
- Oncology
Background:
- Previous studies established a zonal pattern of cyclin D1 expression in benign nevi and malignant melanomas.
- Dysplastic nevi represent an intermediate stage between benign nevi and melanoma.
Purpose of the Study:
- To investigate cyclin D1 expression patterns in dysplastic nevi.
- To correlate cyclin D1 expression with the degree of cytologic atypia in dysplastic nevi.
- To determine if genetic alterations at the cyclin D1 locus contribute to its overexpression in dysplastic nevi.
Main Methods:
- Immunohistochemistry was used to detect cyclin D1 overexpression in 23 dysplastic nevi.
- Dysplastic nevi were graded for atypia as mild, moderate, or severe.
- Fluorescence in situ hybridization (FISH) was performed on selected cases to assess for 11q13 translocation, amplification, or trisomy.
Main Results:
- Cyclin D1 overexpression in dysplastic nevi exhibited a zonal pattern, concentrated at the epidermal-dermal junction, similar to Spitz nevi.
- Increased cyclin D1 expression correlated positively with the severity of cytologic atypia.
- FISH analysis revealed no evidence of cyclin D1 gene amplification, translocation, or trisomy in the evaluated cases.
Conclusions:
- Cyclin D1 overexpression is a feature of dysplastic nevi and may play a role in their pathogenesis.
- The overexpression of cyclin D1 in dysplastic nevi is likely due to mechanisms other than gene amplification or translocation.
- Further research is needed to elucidate the specific cellular abnormalities leading to cyclin D1 upregulation in dysplastic nevi.